SteriWeed | The first bioherbicide blocking germination of herbicide-resistant weeds

Summary
Weeds cause more than 35 Billion € annual global losses, equivalent to 34% of crop yield. If weeds were uncontrolled, about 50% of the crops would be lost. Therefore, synthetic (chemical) herbicides have been used since the late 1940s. However, herbicide’s use has resulted in weed’s evolution. Hence, the most persistent challenge of modern agriculture is the increasing incidence of weed resistance.
Bioherbicides have been introduced as an efficient, yet environmentally-friendly alternative to synthetic herbicides. However, they perform inconsistently, have limited shelf-life, have potential adverse effects for humans and are not economically viable. Therefore, there is an urgent need to develop new technological methods of weed control and management that do not depend on synthetic herbicide use.
We are developing SteriWeed, a novel biological herbicide based on treated pollen and designed to target the resistant-weed and not the crop. It is non-toxic, not chemical engineered, easy to apply and cost-effective. Our innovation lies in its simplicity as the SteriWeed production method consists of only two steps: natural pollen harvesting and irradiation. The results are inviable weeds, unable to produce seeds in the next season.
Today, our team of 6 employees with interdisciplinary background have reached the proof of concept of our technology for A. palmeri, one of the most threaten weeds in the US, reaching outstanding weed control results. The goal of this project is to expand our technology towards the control of the main resistant weeds threatening the European crops.
We estimate that in five years after launching the commercialization phase, SteriWeed will cover over 1.5 million ha across Europe, Israel and USA. We will reach €42 million in cumulative revenues (cumulative profit of €15.5 million – ROI 7.15). We estimate the payback time in beginning of 2023. We plan to hire 11 new professionals, technical experts as well as professionals in business.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/855988
Start date: 01-03-2019
End date: 30-06-2019
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

Weeds cause more than 35 Billion € annual global losses, equivalent to 34% of crop yield. If weeds were uncontrolled, about 50% of the crops would be lost. Therefore, synthetic (chemical) herbicides have been used since the late 1940s. However, herbicide’s use has resulted in weed’s evolution. Hence, the most persistent challenge of modern agriculture is the increasing incidence of weed resistance.
Bioherbicides have been introduced as an efficient, yet environmentally-friendly alternative to synthetic herbicides. However, they perform inconsistently, have limited shelf-life, have potential adverse effects for humans and are not economically viable. Therefore, there is an urgent need to develop new technological methods of weed control and management that do not depend on synthetic herbicide use.
We are developing SteriWeed, a novel biological herbicide based on treated pollen and designed to target the resistant-weed and not the crop. It is non-toxic, not chemical engineered, easy to apply and cost-effective. Our innovation lies in its simplicity as the SteriWeed production method consists of only two steps: natural pollen harvesting and irradiation. The results are inviable weeds, unable to produce seeds in the next season.
Today, our team of 6 employees with interdisciplinary background have reached the proof of concept of our technology for A. palmeri, one of the most threaten weeds in the US, reaching outstanding weed control results. The goal of this project is to expand our technology towards the control of the main resistant weeds threatening the European crops.
We estimate that in five years after launching the commercialization phase, SteriWeed will cover over 1.5 million ha across Europe, Israel and USA. We will reach €42 million in cumulative revenues (cumulative profit of €15.5 million – ROI 7.15). We estimate the payback time in beginning of 2023. We plan to hire 11 new professionals, technical experts as well as professionals in business.

Status

CLOSED

Call topic

EIC-SMEInst-2018-2020

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.0. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-SMEInst-2018-2020-1
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.0. INDUSTRIAL LEADERSHIP - Innovation In SMEs - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-SMEInst-2018-2020-1
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.0. Cross-cutting call topics
H2020-EIC-SMEInst-2018-2020
H2020-SMEInst-2018-2020-1